Hepatocyte nuclear factor-4α interacts with other hepatocyte nuclear factors in regulating transthyretin gene expression.
Transthyretin is a negative acute phase protein whose serum level decreases during the acute phase response. Transthyretin gene expression in the liver is regulated at the transcriptional level, and is controlled by hepatocyte nuclear factor (HNF)-4α and other HNFs. The site-directed mutagenesis of HNF-4, HNF-1, HNF-3 and HNF-6 binding sites in the transthyretin proximal promoter dramatically decreases transthyretin promoter activity. Interestingly, the mutation of the HNF-4 binding site not only abolishes the response to HNF-4α, but also reduces significantly the response to other HNFs. However, mutation of the HNF-4 binding site merely affects the specific binding of HNF-4α, but not other HNFs, suggesting that an intact HNF-4 binding site not only provides a platform for specific interaction with HNF-4α, but also facilitates the interaction of HNF-4α with other HNFs. In a cytokine-induced acute phase response cell culture model, we observed a significant reduction in the binding of HNF-4α, HNF-1α, HNF-3β and HNF-6α to the transthyretin promoter, which correlates with a decrease in transthyretin expression after injury. These findings provide new insights into the mechanism of the negative transcriptional regulation of the transthyretin gene after injury caused by a decrease in the binding of HNFs and a modulation in their coordinated interactions.
Wang
Zhongyan
Z
Department of Surgery, Boston University School of Medicine, Boston, MA 02118, USA.
Burke
Peter A
PA
D000818:Animals; D001483:Base Sequence; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000503:physiopathology; D045744:Cell Line, Tumor; D015536:Down-Regulation; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D006041:Goats; D051557:Hepatocyte Nuclear Factor 4 / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism / Q000502:physiology*; D051536:Hepatocyte Nuclear Factors / Q000235:genetics / Q000502:physiology*; D006801:Humans; D015151:Immunoblotting; D008113:Liver Neoplasms / Q000235:genetics / Q000473:pathology; D009154:Mutation; D010957:Plasmids / Q000235:genetics; D011228:Prealbumin / Q000235:genetics*; D011401:Promoter Regions, Genetic; D011817:Rabbits; D014158:Transcription, Genetic
D051557:Hepatocyte Nuclear Factor 4; D051536:Hepatocyte Nuclear Factors; D011228:Prealbumin